Results 121 to 130 of about 51,459 (306)

Diagnostic validation of the 00325 Inadequate Self‐Compassion

International Journal of Nursing Knowledge, EarlyView.
Abstract Background Self‐compassion is an essential component of self‐care. Recognizing it as a nursing diagnosis can promote interventions to address Inadequate Self‐Compassion. Aim This study aims to clinically validate the new NANDA‐I diagnosis (00325) Inadequate Self‐Compassion.
Aarón Muñoz‐Devesa, Daniel Guillén‐Martínez, Adriana Caterina de Souza‐Oliveira, Daniel Muñoz‐Jimenez, Paloma Echevarría‐Pérez, Isabel Morales‐Moreno   +5 more
wiley   +1 more source

Pineal Gland Volume, Sleep Quality, and Psychiatric Disorders: A Systematic Review and Meta‐Analysis

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Disturbances in sleep and circadian rhythms are features of several psychiatric disorders. The pineal gland regulates these rhythms via melatonin, with pineal gland volume (PGV) serving as a structural proxy. We conducted a meta‐analysis to synthesize evidence on differences in PGV between patients with psychiatric disorders and ...
Sophie Bolwig, Kristian H. R. Jensen
wiley   +1 more source

Effectiveness of a Psychiatrist‐Led Clinic for Metabolic Health in Severe Mental Illness: A Retrospective Chart Review Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Psychotropic medications are associated with serious metabolic adverse effects, which contribute to an increased risk of cardiometabolic comorbidities in patients with severe mental illness (SMI). Several intervention strategies are available to mitigate these metabolic adverse effects; however, data on their utility in real‐world ...
Nicolette Stogios, Femin Prasad, Riddhita De, Kateryna Maksyutynska, Akash PrasannaKumar, Vittal Korann, Tariq Ahmed, Marcos Sanches, Leah Burton, Mohammed A. Alarabi, Tanner Isinger, Michelle Desanti, Rebecca Oliveira, Daphne J. Korczak, Ariel Graff‐Guerrero, Gary Remington, Margaret K. Hahn, Sri Mahavir Agarwal   +17 more
wiley   +1 more source

Comparative Clinical Trajectories Across Cannabis‐Related and Nonsubstance‐Related Psychoses

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Research indicates that first‐episode psychosis (FEP) with cannabis use disorder (CUD) carries a substantial disease burden, but more granular clinical trajectories of cannabis‐related psychoses remain unclear. This study examines the clinical trajectories of first clinically diagnosed FEP&CUD and cannabis‐induced psychosis (CIP) in
Antti Mustonen, Solja Niemelä, Alexander Denissoff, Antti Tanskanen, Ellenor Mittendorfer‐Rutz, Markku Lähteenvuo, Jari Tiihonen, Heidi Taipale   +7 more
wiley   +1 more source

Selective Serotonin Reuptake Inhibitor Treatment in Adolescence and Subsequent Risk of Nonaffective Psychosis: A Quasi‐Experimental Study

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Objective Psychotic disorders are frequently preceded by common mental disorders (CMDs), like depression and anxiety. It remains unclear whether treating CMDs in adolescence can reduce subsequent psychosis risk. We applied quasi‐experimental methods to national register data to assess whether a causal relationship exists between selective ...
Ioanna Kougianou, Animesh Talukder, Kirstie O′ Hare, Colm Healy, Ian Kelleher   +4 more
wiley   +1 more source

Watsuji's phenomenology of aidagara: An interpretation and application to psychopathology [PDF]

I discuss Watsuji’s characterization of aidagara or “betweenness”. First, I develop a phenomenological reading of aidagara. I argue that the notion can help illuminate aspects of our embodied subjectivity and its interrelation with the world and others ...
Krueger, Joel
core  

Blood Alcohol Concentration in Finnish Suicide Deaths and Associated Risk Factors, 2016–2024

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Aims There is limited research examining the relationship between blood alcohol concentration (BAC) and other risk factors among suicide deaths in Finland. Our study aimed to investigate the relationship of an elevated (more than zero) blood alcohol concentration with medical history, including sociodemographic characteristics and disease ...
Tristan Pokornyi, Marjut Grainger, Timo Partonen   +2 more
wiley   +1 more source

ETHNOPSYCHIATRIC INTERPRETATIONS OF SCHIZOPHRENIC ILLNESS: THE PROBLEM OF NERVIOS WITHIN MEXICAN-AMERICAN FAMILIES [PDF]

, 1988
A. Kiev, A. Kleinman, A. Kleinman, A. Kleinman, B. J. Good, B. J. Good, B. J. Good, C. Hughes, C. Lutz, C. Lutz, C. Lutz, C. Vaughn, C. Vaughn, C. Vaughn, E. Schieffelin, F. Myers, F. Newton, G. Brown, G. W. Brown, G. White, H. Fabrega, H. Fabrega, H. Rin, I. Cuellar, I. I. Gottesman, J. H. Jenkins, J. H. Jenkins, J. Henry, J. M. Gilbert, J. M. Janzen, J. Murphy, J. Murphy, J. Townsend, J. Townsend, L. Rogler, L. Wynne, M. Bleuler, M. Karno, M. Locke, M. Rosaldo, M. Tousignant, N. Murillo, N. Sartorius, N. Scheper-Hughes, N. Scheper-Hughes, N. Waxler, O. Ramirez, R. B. Edgerton, R. B. Edgerton, R. B. Edgerton, R. C. Solomon, S. E. Keefe, S. Estroff, S. Estroff, S. Keefe, S. Low, S. Low, T. Y. Lin, V. Gecas, World Health Organization   +59 more
core   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source